Results 101 to 110 of about 2,547 (193)

Kıbrıs Rum Ortodoks Kilisesi Ve Enosis Politikaları

, 2016
ÖNSÖZ: Osmanlı’nın Ada’yı fethini müteakip, Ortodoks Kilisesi’ni yeniden canlandırdığı, birçok idari ve ekonomik ayrıcalıklar tanıdığı dönemden başlayarak, Osmanlı Yönetimi, İngiliz Yönetimi ve daha sonraki Kıbrıs Cumhuriyeti dönemi ile sonraki süreçte Ortodoks Kilisesinin durumunu incelediğimiz zaman, Kıbrıs’ta Kilise’nin politika üretilmesindeki ...
openaire   +1 more source

Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors. [PDF]

J Hematol Oncol, 2021
Terpos E, Zagouri F, Liontos M, Sklirou AD, Koutsoukos K, Markellos C, Briasoulis A, Papanagnou ED, Trougakos IP, Dimopoulos MA.   +9 more
europepmc   +1 more source

Cyprus: A Unique Opportunity for Reunification [PDF]

, 2009
Greek and Turkish Cypriots have been negotiating a settlement to end the 35-year division of Cyprus, invaded by Turkey following inter-communal strife, for more than a year with little apparent progress.
Chislett, William
core  

Flow Cytometry, a Unique Biotechnology in Medical Applications. [PDF]

J Clin Med, 2022
Lambert C.
europepmc   +1 more source

Kinetics of Anti-SARS-CoV-2 Antibody Responses 3 Months Post Complete Vaccination with BNT162b2; A Prospective Study in 283 Health Workers. [PDF]

Cells, 2021
Terpos E, Trougakos IP, Karalis V, Ntanasis-Stathopoulos I, Gumeni S, Apostolakou F, Sklirou AD, Gavriatopoulou M, Skourti S, Kastritis E, Korompoki E, Papassotiriou I, Dimopoulos MA.   +12 more
europepmc   +1 more source

Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP Inhibitors. [PDF]

Vaccines (Basel), 2021
Liontos M, Terpos E, Markellos C, Zagouri F, Briasoulis A, Katsiana I, Skafida E, Fiste O, Kunadis E, Andrikopoulou A, Kaparelou M, Koutsoukos K, Gavriatopoulou M, Kastritis E, Trougakos IP, Dimopoulos MA.   +15 more
europepmc   +1 more source

The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment. [PDF]

Blood Cancer J, 2021
Terpos E, Gavriatopoulou M, Ntanasis-Stathopoulos I, Briasoulis A, Gumeni S, Malandrakis P, Fotiou D, Papanagnou ED, Migkou M, Theodorakakou F, Roussou M, Eleutherakis-Papaiakovou E, Kanellias N, Trougakos IP, Kastritis E, Dimopoulos MA.   +15 more
europepmc   +1 more source

Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients. [PDF]

BMC Med, 2021
Trougakos IP, Terpos E, Zirou C, Sklirou AD, Apostolakou F, Gumeni S, Charitaki I, Papanagnou ED, Bagratuni T, Liacos CI, Scorilas A, Korompoki E, Papassotiriou I, Kastritis E, Dimopoulos MA.   +14 more
europepmc   +1 more source

Recovery of Innate Immune Cells and Persisting Alterations in Adaptive Immunity in the Peripheral Blood of Convalescent Plasma Donors at Eight Months Post SARS-CoV-2 Infection. [PDF]

Microorganisms, 2021
Kostopoulos IV, Orologas-Stavrou N, Rousakis P, Panteli C, Ntanasis-Stathopoulos I, Charitaki I, Korompoki E, Gavriatopoulou M, Kastritis E, Trougakos IP, Dimopoulos MA, Tsitsilonis OE, Terpos E.   +12 more
europepmc   +1 more source

SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors. [PDF]

Breast, 2021
Zagouri F, Terpos E, Fiste O, Liontos M, Briasoulis A, Katsiana I, Skafida E, Markellos C, Kunadis E, Andrikopoulou A, Kaparelou M, Koutsoukos K, Gavriatopoulou M, Kastritis E, Trougakos IP, Dimopoulos MA.   +15 more
europepmc   +1 more source